Cleared Traditional

K770868 - CATHETER

K770868 is an FDA 510(k) clearance for CATHETER, manufactured by Abbott Laboratories. The device is a Class 2 Cardiovascular device with product code DQO cleared through the Traditional 510(k) pathway after a 46-day FDA review.

K770868 · Abbott Laboratories · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1977
Decision
46d
Days
Class 2
Risk

K770868 is an FDA 510(k) clearance for the CATHETER, POLYURETHANE, W/STYLET. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on June 27, 1977 after a review of 46 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K770868

510(k) Number K770868 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 12, 1977
Decision Date June 27, 1977
Days to Decision 46 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
79d faster than avg
Panel avg: 125d · This submission: 46d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQO Device Classification - Class 2, Special Controls

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 319
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K770868.
PRESSURE MONITORING INJECTION LINES
K781558 · Cobe Laboratories, Inc. · Oct 1978
MYOCATH KIT
K780529 · Sorensen Research · May 1978
PRESSURE TUBING
K771810 · Pharmaseal Div., Baxter Healthcare Corp. · Nov 1977
MONITORING KIT, CENTRAL VENOUS PRESSURE
K770290 · Argon Medical Corp. · Mar 1977
PUNCTURE KIT, INTERNAL JUGULAR
K770462 · Arrow Intl., Inc. · Mar 1977